Pembrolizumab (Keytruda)

  • How it’s given: an IV infusion every 3 or 6 weeks, depending on your treatment plan

  • Common side effects: fatigue, cough, rash, diarrhea, nausea, and joint pain

  • Immune-related side effects: Keytruda can affect the lungs, liver, thyroid, colon, and other organs — report new or unusual symptoms immediately

  • Fever or signs of infection: Call your oncology team right away if your temperature is ≥100.4°F (38°C)

Our goal is to help you understand your treatment, manage side effects, and feel supported throughout your therapy.

Return to Treatments
Video Survey